Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Completed · Phase 2

Conditions studied: Warts

In brief

The primary purpose of this study is to evaluate the effectiveness in adults, of four different strengths of resiquimod gel applied to common wart(s) three times a week for twelve weeks. A second purpose is to evaluate the safety of the drug.

Key facts

Study ID

NCT00114920

Run by

Graceway Pharmaceuticals, LLC

People needed

88

Starts

2004-03-01

Last updated by the study team

2007-02-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of common warts
• Two forms of birth control

You may not qualify if…

• Pregnant or breast feeding
• Other types of wart(s), ie. plantar
• Currently participating in another clinical study
• Chronic viral hepatitis B or C

Where it is running

• Welborn Clinic — Evansville, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.